Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report

Introduction: Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a group of multisystemic autoimmune diseases that can involve organs such as kidneys and respiratory tracts. Since the initiation COVID-19 vaccines, there have been few cases antineutrophil antibody (ANCA) glomerulonephritis development after receiving vaccine doses. Case Presentation: This report describes 15-year-old man who has developed ANCA-associated (AAGN) second dose BBIBP-CorV (Sinopharm) vaccine. Conclusions: Development AAGN both natural SARS-CoV-2 infection following other vaccinations raises question possible causality between two. Considering widespread use it highly important to investigate their side effects.